These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 39184178)

  • 21. Association between polygenic risk score of Alzheimer's disease and plasma phosphorylated tau in individuals from the Alzheimer's Disease Neuroimaging Initiative.
    Zettergren A; Lord J; Ashton NJ; Benedet AL; Karikari TK; Lantero Rodriguez J; ; Snellman A; Suárez-Calvet M; Proitsi P; Zetterberg H; Blennow K
    Alzheimers Res Ther; 2021 Jan; 13(1):17. PubMed ID: 33419453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of
    Xicota L; Gyorgy B; Grenier-Boley B; Lecoeur A; Fontaine G; Danjou F; Gonzalez JS; Colliot O; Amouyel P; Martin G; Levy M; Villain N; Habert MO; Dubois B; Lambert JC; Potier MC;
    Neurology; 2022 Aug; 99(5):e462-e475. PubMed ID: 35606148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebrospinal fluid biomarkers and cognitive trajectories in patients with Alzheimer's disease and a history of traumatic brain injury.
    van Amerongen S; Das S; Kamps S; Goossens J; Bongers B; Pijnenburg YAL; Vanmechelen E; Vijverberg EGB; Teunissen CE; Verberk IMW
    Neurobiol Aging; 2024 Sep; 141():121-128. PubMed ID: 38908030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-reported traumatic brain injury and in vivo measure of AD-vulnerable cortical thickness and AD-related biomarkers in the ADNI cohort.
    Wang ML; Wei XE; Yu MM; Li PY; Li WB;
    Neurosci Lett; 2017 Aug; 655():115-120. PubMed ID: 28689050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
    Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S;
    Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood Derived Amyloid Biomarkers for Alzheimer's Disease Prevention.
    Udeh-Momoh C; Zheng B; Sandebring-Matton A; Novak G; Kivipelto M; Jönsson L; Middleton L
    J Prev Alzheimers Dis; 2022; 9(1):12-21. PubMed ID: 35098969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
    Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
    J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Alzheimer's disease-associated risk loci on cerebrospinal fluid biomarkers and disease progression: a polygenic risk score approach.
    Martiskainen H; Helisalmi S; Viswanathan J; Kurki M; Hall A; Herukka SK; Sarajärvi T; Natunen T; Kurkinen KM; Huovinen J; Mäkinen P; Laitinen M; Koivisto AM; Mattila KM; Lehtimäki T; Remes AM; Leinonen V; Haapasalo A; Soininen H; Hiltunen M
    J Alzheimers Dis; 2015; 43(2):565-73. PubMed ID: 25096612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beneficial association of angiotensin-converting enzyme inhibitors and statins on the occurrence of possible Alzheimer's disease after traumatic brain injury.
    Li M; Reisman J; Morris-Eppolito B; Qian SX; Kazis LE; Wolozin B; Goldstein LE; Xia W
    Alzheimers Res Ther; 2020 Mar; 12(1):33. PubMed ID: 32220235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
    Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
    Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of traumatic brain injury and posttraumatic stress disorder on development of Alzheimer's disease in Vietnam Veterans using the Alzheimer's Disease Neuroimaging Initiative: Preliminary Report.
    Weiner MW; Harvey D; Hayes J; Landau SM; Aisen PS; Petersen RC; Tosun D; Veitch DP; Jack CR; Decarli C; Saykin AJ; Grafman J; Neylan TC;
    Alzheimers Dement (N Y); 2017 Jun; 3(2):177-188. PubMed ID: 28758146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of CSF α-synuclein and amyloid beta in cognition and cortical atrophy.
    Lee YG; Jeon S; Kang SW; Park M; Baik K; Yoo HS; Chung SJ; Jeong SH; Jung JH; Lee PH; Sohn YH; Evans AC; Ye BS;
    Alzheimers Dement (Amst); 2021; 13(1):e12177. PubMed ID: 34046519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between Cerebrospinal Fluid Core Alzheimer's Disease Biomarkers and β-Amyloid PET in Chinese Dementia Population.
    Xie Q; Ni M; Gao F; Dai LB; Lv XY; Zhang YF; Shi Q; Zhu XX; Xie JK; Shen Y; Wang SC
    ACS Chem Neurosci; 2022 May; 13(10):1558-1565. PubMed ID: 35476397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polygenic Risk Score Reveals Genetic Heterogeneity of Alzheimer's Disease between the Chinese and European Populations.
    Li F; Xie S; Cui J; Li Y; Li T; Wang Y; Jia J
    J Prev Alzheimers Dis; 2024; 11(3):701-709. PubMed ID: 38706286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sleep and Tau Pathology in Vietnam War Veterans with Preclinical and Prodromal Alzheimer's Disease.
    Andrews M; Ross R; Malhotra A; Ancoli-Israel S; Brewer JB; Banks SJ;
    J Alzheimers Dis Rep; 2021 Jan; 5(1):41-48. PubMed ID: 33681715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Polygenic Risk Score with Age at Onset and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease in a Chinese Cohort.
    Li WW; Wang Z; Fan DY; Shen YY; Chen DW; Li HY; Li L; Yang H; Liu YH; Bu XL; Jin WS; Zeng F; Xu ZQ; Yu JT; Chen LY; Wang YJ
    Neurosci Bull; 2020 Jul; 36(7):696-704. PubMed ID: 32072450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amyloid-β Peptides and Tau Protein as Biomarkers in Cerebrospinal and Interstitial Fluid Following Traumatic Brain Injury: A Review of Experimental and Clinical Studies.
    Tsitsopoulos PP; Marklund N
    Front Neurol; 2013; 4():79. PubMed ID: 23805125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Pathway-specific Polygenic Risk Scores for Alzheimer's Disease (AD) on Rate of Change in Cognitive Function and AD-related Biomarkers among Asymptomatic Individuals.
    Xu Y; Vasiljevic E; Deming YK; Jonaitis EM; Koscik RL; Van Hulle CA; Lu Q; Carboni M; Kollmorgen G; Wild N; Carlsson CM; Johnson SC; Zetterberg H; Blennow K; Engelman CD
    medRxiv; 2023 Feb; ():. PubMed ID: 36778431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiorespiratory fitness alters the influence of a polygenic risk score on biomarkers of AD.
    Schultz SA; Boots EA; Darst BF; Zetterberg H; Blennow K; Edwards DF; Koscik RL; Carlsson CM; Gallagher CL; Bendlin BB; Asthana S; Sager MA; Hogan KJ; Hermann BP; Cook DB; Johnson SC; Engelman CD; Okonkwo OC
    Neurology; 2017 Apr; 88(17):1650-1658. PubMed ID: 28341646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.